ANDRÉS JESÚS
MUÑOZ MARTÍN
Profesor asociado


Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (60)
2024
-
Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO)
Thrombosis Update, Vol. 17
-
Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)
Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2388-2392
-
Correction to: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing (Clinical and Translational Oncology, (2024), 10.1007/s12094-024-03586-2)
Clinical and Translational Oncology
-
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
Clinical and Translational Oncology
-
Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study
Clinical and Translational Oncology
-
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 6, pp. 1319-1328
-
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Clinical and Translational Oncology
-
Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM)
European Journal of Internal Medicine, Vol. 130, pp. 98-105
-
Up and down in gastrointestinal cancer and bleeding with direct oral anticoagulants
European Journal of Internal Medicine
-
Update in venous thromboembolism in cancer: Lessons from multi-centre registries
Thrombosis Update, Vol. 16
-
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177
2023
-
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2911-2925
-
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive
Internal and Emergency Medicine, Vol. 18, Núm. 6, pp. 1619-1634
-
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents
Seminars in Oncology, Vol. 50, Núm. 3-5, pp. 67-70
-
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
Thrombosis Research, Vol. 232, pp. 133-137
-
Ictus asociado a cáncer: estudio de prevalencia y factores predictores entre pacientes con ictus isquémico
Revista de neurologia, Vol. 76, Núm. 6, pp. 189-195
-
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Clinical and Translational Oncology, Vol. 25, Núm. 10, pp. 3021-3031
-
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study
PLoS ONE, Vol. 18, Núm. 5 May
-
Reply to F.I. Mulder et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 36, pp. 5595
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347